Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04CAR
|
|||
Former ID |
DNC008931
|
|||
Drug Name |
(R)-1-(2-aminoacetyl)pyrrolidin-2-ylboronic acid
|
|||
Synonyms |
Gly-boroPro; CHEMBL67089; Glycinyl-(R)-Boroproline; (R)-1-(2-aminoacetyl)pyrrolidin-2-ylboronic acid; SCHEMBL10022738
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C6H13BN2O3
|
|||
Canonical SMILES |
B(C1CCCN1C(=O)CN)(O)O
|
|||
InChI |
1S/C6H13BN2O3/c8-4-6(10)9-3-1-2-5(9)7(11)12/h5,11-12H,1-4,8H2/t5-/m0/s1
|
|||
InChIKey |
BZTBBVKEKPNNBE-YFKPBYRVSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dipeptidyl peptidase 4 (DPP-4) | Target Info | Inhibitor | [1] |
KEGG Pathway | Protein digestion and absorption | |||
NetPath Pathway | IL2 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety. J Med Chem. 2008 Oct 9;51(19):6005-13. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.